Work

Abstract CT242: A phase 2 study of BPM31510 (a lipid nanodispersion of oxidized CoQ10) with vitamin K in combination with standard of care (SOC) RT and TMZ in glioblastoma multiforme (GBM) patients without prior therapy

Year: 2025

Type: conference-abstract

Source: Cancer Research

DOI: 10.1158/1538-7445.am2025-ct242

Authors: Brian Stocksdale, Rebecca Brown, Kevin Elmore, Chirag Patel, Adam Cohen, Rupa Juthani, Brian Vaillant, Alexander Spira, Jedrzej Wykretowicz, Bing Nie, Michael A. Kiebish, Stephane Gesta, Niven R. Narain, Vijay Modur, Seema Nagpal

Institutions: Stanford University, Icahn School of Medicine at Mount Sinai, Cedars-Sinai Medical Center, Valley Health System, Texas Oncology, Virginia Cancer Specialists, Virginia Oncology Associates, BPGbio, Inc. (United States)

Language: English

Topic: Glioma Diagnosis and Treatment

Subfield: Genetics

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W4409821736

Cites:

Cited by:

Related to: 10